Skip to content

What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis

What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03622853
Enrollment
100
Registered
2018-08-09
Start date
2018-01-01
Completion date
2019-03-01
Last updated
2018-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Capsulitis

Keywords

adhesive capsulitis

Brief summary

To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder

Detailed description

Objective: To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder Design: Prospective study. Participants: Patients with Frozen shoulder were recorded the demographic data, associated disease, ultrasound findings at baselines. Intervention: One shot intraarticular steroid hydrodilatation Main Outcome Measures: Visual analog scale (VAS) of the shoulder pain, Constant score, SPADI score, and angles of active and passive shoulder range of motion (flexion, abduction, external rotation, and internal rotation) at pre-treatment, post-treatment at week 8

Interventions

DRUGSteroid (shincort)

intraarticular shincort 40mg / 4ml mixed with 2% xylocaine and Normal saline

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of frozen shoulder by physical examination and ultrasonography

Exclusion criteria

1. other conditions involving the shoulder ( rheumatoid arthritis, Hill-Sachs lesions,osteoporosis, or malignancies in the shoulder region); 2. neurologic deficits affecting shoulder function in normal daily activities; 3. shoulder pain caused by cervical radiculopathy 4. a history of drug allergy to xylocaine 5. pregnancy or lactation; 6. received injection into the affected shoulder during the preceding 3 months

Design outcomes

Primary

MeasureTime frameDescription
The change of constant shoulder score between week 0 and week 80 and 8 wksthe total constant score ranges from 0 to 100 points, with higher scores indicative of better function. The score is divided into four sections: pain, activity of daily living, ROM and strength

Secondary

MeasureTime frameDescription
pain intensity0 and 8 wkspain intensity was measured by visual analog scale. Each patient was asked to indicate his/her current level of pain by marking a point on a 100-mm VAS, for which 0 represented no pain and 100 represented unbearable pain.
Shoulder Pain And disability index0 and 8 wksThe Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder.
glenohumeral joint range of motion0 and 8 wksShoulder flexion, abduction, external rotation and internal rotation were measured with goniometer with patient in supine position

Countries

Taiwan

Contacts

Primary ContactJia chi c Wang, MD
jcwang0726@gmail.com919527693

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026